Actively Recruiting
Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region
Led by Umeå University · Updated on 2022-01-05
500
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an observational study to analyze factors that predict outcomes and guide diagnosis and surgical treatment for cysts and tumors in the pancreas and periampullary area. This research uses clinical data along with blood and tissue samples to develop and validate biomarkers. The study includes both retrospective enrollment and prospective enrollment starting from November 2021, aiming to understand clinical outcomes and prognostic factors based on patient and tumor characteristics. Participants recommended for surgery due to tumors or cysts in the pancreas or periampullary region are included in this study. The research involves collecting and reviewing electronic medical records and biological samples. There are no specific treatment groups or interventions, as the study observes and records outcomes over time. During the study, participants' clinical data and surgical outcomes are monitored, focusing on overall survival over 10 years as the primary measure. Secondary outcomes include complication rates and the extent of tumor removal (radical resection) over the same period. The study includes both living participants who provide consent and retrospective data from deceased individuals. The long-term follow-up offers insights into surgical care and outcomes for these conditions.
CONDITIONS
Brief Title
Prognostic Factors in Periampullary Tumors and Cysts
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recommended surgery for tumor or cyst in the pancreas or periampullary region
- Information available in electronic journal files
- Informed consent given (or deceased for retrospective part of the study)
You will not qualify if you...
- No informed consent and still alive at study initiation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants are observed over time to collect information on clinical outcomes and prognostic factors related to pancreas and periampullary tumors and cysts.
Trial Site Locations
Total: 1 location
1
Surgical Clinic at Umeå University Hospital
Umeå, Sweden, 90185
Actively Recruiting
Research Team
O
Oskar Franklin, MD/PhD
A
Asif Halimi, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here